Samrat Pharmachem Balance Sheet Health
Financial Health criteria checks 6/6
Samrat Pharmachem has a total shareholder equity of ₹694.1M and total debt of ₹91.4M, which brings its debt-to-equity ratio to 13.2%. Its total assets and total liabilities are ₹1.3B and ₹602.5M respectively. Samrat Pharmachem's EBIT is ₹68.1M making its interest coverage ratio 26.9. It has cash and short-term investments of ₹71.9M.
Key information
13.2%
Debt to equity ratio
₹91.37m
Debt
| Interest coverage ratio | 26.9x |
| Cash | ₹71.92m |
| Equity | ₹694.15m |
| Total liabilities | ₹602.51m |
| Total assets | ₹1.30b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 530125's short term assets (₹1.1B) exceed its short term liabilities (₹602.5M).
Long Term Liabilities: 530125 has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: 530125's net debt to equity ratio (2.8%) is considered satisfactory.
Reducing Debt: 530125's debt to equity ratio has reduced from 48.3% to 13.2% over the past 5 years.
Debt Coverage: 530125's debt is well covered by operating cash flow (208.6%).
Interest Coverage: 530125's interest payments on its debt are well covered by EBIT (26.9x coverage).